BKV and JCV biology
the presence of BKV DNA in the serum [2] . The disease may be, in part, a result of the introduction of new immunosuppressive drugs [6 ] . Reduction in the Primary BKV infections occur in early childhood and immunosuppressive therapy often leads to improved primary JCV infections in late childhood. Both viruses clinical outcome. remain latent in the kidney and in B lymphocytes after primary infection. Almost all illnesses attributable to BKV and JCV occur in the background of immuno-
Role of donor kidney
deficiency, most often as a result of reactivation of the latent virus. JCV is the aetiologic agent of PML, a fatal, subacute, progressive demyelinating disease of BKV in donor kidney is a determinant of BKV infection in the recipient. Previous studies of paired serum the brain, which occurs as a complication of AIDS and other immunosuppressive conditions. In contrast specimens have shown that about a quarter of BKV infections (as determined by a 4-fold or greater rise in to the tropism of JCV for brain, BKV-related pathology is largely confined to the urinary tract.
BKV antibody titer) in renal transplant recipients occur in individuals who have no detectable antibodies in Some simian polyomaviruses produce illnesses in their natural hosts which closely resemble human their first serum, i.e. they are primary infections [8] .
This is in contrast to BKV infections in bone marrow illnesses caused by JCV and BKV. Simian virus 40, an indigenous polyomavirus infection of rhesus macaques, produces a PML-like neurological disease in animals cInfection assessed by rise in antibody titer.
member of the polyoma virus family causes interstitial nephritis, transplant recipients and in pregnant women, which ureteritis, and enteritis in immunosuppressed cynomolgus monare almost always due to reactivation of latent BKV.
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